Health
Results: 8809-8820 of 9417

Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting

Elsevier introduces authoritative scientific Datasets to fuel innovation and business-critical decisions in life sciences, chemicals and other research-intensive industries

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening





